Objective: To evaluate, using indicators, the impact of an oncology-monitoring program on activity and organizational fluidity in a Cytotoxic Preparation Unit (CPU) and clinical departments. To identify positive and negative points of this program. Method: Collection of clinical and biological data between two injections by calling up the patient two days prior chemotherapy is performed by a specialist nurse of an outsourced medical call center. Data security is guaranteed by a licensed healthcare data host. After medical and pharmaceutical validation, early preparations (D-1) for expensive and non-expensive molecules are performed. Results: The program started in February 2016. After 4 months, 430 patients were included into the program. 23 patients on average are called per day related to 1860 completed clinical questionnaires (87 %). 47 % of files are complete at D-2 (biological and clinical data). The early preparation rate of expensive drugs, zero before the program, has reached 37 % at 4 months. The destroyed preparation rate because of non-administration decreased from 5 % to 2 %. Discussion: Preliminary results show a significant patient compliance, feasibility of early preparation of expensive and non-expensive chemotherapy. These are preliminary results of a one year study. They will be completed by an evaluation of patients' and health professionals' satisfaction, reduction of waiting time, optimization of operations for clinical departments and CPU. The D-2 biological data collection is the significant difficulty and limits efficiency of this program. A reorganization of professional practices and a strong doctor /pharmacist collaboration are essential for better patient care pathway.
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